Many kids in South Africa, especially those who can’t afford monthly doctor’s visits, don’t access their attention deficit ...

The Food and Drug Administration is currently reviewing a first-of-its-kind, twice-yearly injectable medication that experts say could revolutionize HIV prevention. The drug, Lenacapavir, has shown ...

The medication, Lenacapavir, is said to have shown exceptional promise in clinical trials, and some of the research is being ...

In 2021, approval of cabotegravir (Apretude) as the first long-acting PrEP option provided patients an option to move from ...

People living with HIV have a significantly increased risk of cardiovascular disease that requires a different level of ...

Drugmaker Gilead Sciences is not only providing the shot in the US, but is also working with governments and health groups in the UK and low-income countries to make these products more available.

A major bottleneck in curing HIV (human immunodeficiency virus) is that the virus can hide in an inactive form within resting ...

Researchers have never seen anything as close to a potential HIV cure as this new nanoparticle approach. As study authors ...